Depression

The anatomy of unhappiness is more complex than DSM-5’s categories.

VistaGen Therapeutic’s grant application for PH10, an investigational therapeutic agent for the treatment of depression, has been approved.

Are patients with depression and substance use disorder getting an appropriate level of care? Our Journal Club piece investigates.

One medication stood out as the most effective in a meta-analysis of alcohol use disorders with depression, but few patients are taking it.

A new study finds that isolation makes us want company on a neural level, in much the same way that hunger makes us want food.

Depression can cause weight loss or a loss of appetite... or it could cause weight gain and an increased appetite. Here is some need-to-know information on weight control and mood disorders.

Fluvoxamine was not intended as a COVID-19 medication, but a recent study suggests it may help prevent serious complications for patients with COVID-19.

A healthy diet can improve mood and effectiveness of antidepressant medications. Here's why your patients should be eating healthier.

Patients' first reactions to a diagnosis of major depressive disorder can be varied. What can you do to help them cope?

Exercise can be a useful tool in managing symptoms of anxiety and depression. Learn how you can integrate exercise prescriptions into your treatment plans.

A controversial report from the British Psychological Society draws a pair of sharp rejoinders.

A study in Spain uncovers the hard truth about gender inequality in mental health care.

Learn about REL-1017, the medication that has the potential to be the first single agent oral NMDAR antagonist for the adjunctive treatment of depression.

A diagnosis of depression, anxiety disorders, or bulimia may also indicate a heightened risk of excessive drinking.

Raise the dose, augment, or switch? A new study suggests we may need to give antidepressants more time to be effective.

Does race affect the risk of stroke in patients with depression? A new study finds some answers and some new questions.

What are the 3 signs, or horsemen, of physicians struggling?

VistaGen Therapeutics CEO Shawn Singh discusses what he and VistaGen are doing to create and improve treatments that complement your practice.

Benzodiazepines, a drug used to treat anxiety and other conditions, has been mandated to alter their safety warnings. Read about the latest.

Job loss may negatively impact your patient’s mental health. Read about how you can help.

Read about the new results from Sage’s clinical study of depression treatment, zuranolone.

Terrorism is a crime from which the families of the victims may never recover. A recent study examines the grieving process in depth.

Dak Prescott of the Dallas Cowboys spoke up about his mental illness and was questioned. Dr Calhoun argues his bravery should be commended, not criticized.

What happens when a patients decides to quit taking a serotonin reuptake inhibitor?

Individuals who are anxious and depressed are more likely to avoid necessary medical care, even during a pandemic.